Article

Airway Stability Achievable in GPA Patients

British clinicians share their experience with the management of airway stenosis in granulomatosis with polyangiitis. Treatment succeeds, but recurrence is common.

Martinez Del Pero M, Jayne D, Chaudhry A, et al. Long-term Outcome of Airway Stenosis in Granulomatosis With Polyangiitis (Wegener Granulomatosis) An Observational Study. JAMA Otolaryngol Head Neck Surg. (2014) Published online October 16, 2014.  doi:10.1001/jamaoto.2014.2430

Most patients with granulomatosis with polyangiitis (GPA) who experience airway stenoses benefit from long periods of airway stability with treatment, but recurrence is common and requires lifelong follow-up, according to British head and neck specialists.

They offer one of the largest published series on airway management in GPA (previously known as Wegener granulomatosis), describing the epidemiology, treatments and outcomes at a British tertiary referral center. They also discuss their preferred algorithm to manage the condition.

At their institution, they saw 251 patients for GPA during a 15-year period, and nearly 20% had airway stenosis. The most common diagnoses were subglottic stenosis and lower airway stenosis.

The 39 patients who underwent balloon, bougie, or dilatation and laser interventions did require multiple procedures, but 97% achieved a prolonged period of airway patency.

However, recurrence of stenosis is independent of disease activity and the site of recurrence may change over time, the authors caution.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.